This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Apr 2;299(13):1605-6.

doi: 10.1001/jama.299.13.1605.

Use of gene signatures to improve risk estimation in cancer

Chiang-Ching Huang, Markus Bredel

PMID: 18387936
DOI: 10.1001/jama.299.13.1605

Editorial

Use of gene signatures to improve risk estimation in cancer

Chiang-Ching Huang et al. JAMA. 2008.

. 2008 Apr 2;299(13):1605-6.

doi: 10.1001/jama.299.13.1605.

Authors

Chiang-Ching Huang, Markus Bredel

PMID: 18387936
DOI: 10.1001/jama.299.13.1605

No abstract available

PubMed Disclaimer

Comment on

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A. Acharya CR, et al. JAMA. 2008 Apr 2;299(13):1574-87. doi: 10.1001/jama.299.13.1574. JAMA. 2008. Retraction in: JAMA. 2012 Feb 1;307(5):453. doi: 10.1001/jama.2012.2. PMID: 18387932 Retracted.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information